Omead Ostadan
Directeur Général chez Cellanome, Inc.
Profil
Actuellement, Omead Ostadan occupe le poste de président, directeur de l'exploitation et directeur chez Seer, Inc. (Californie). Dans le passé, il a été premier vice-président, directeur des produits et du marketing chez Illumina, Inc. et vice-président du marketing chez Solexa, Inc. (une filiale d'Illumina, Inc.). M. Ostadan est titulaire d'un diplôme de premier cycle de l'Université de Californie, Davis, et d'un MBA de la Wharton School de l'Université de Pennsylvanie.
Postes actifs de Omead Ostadan
Sociétés | Poste | Début |
---|---|---|
Cellanome, Inc.
Cellanome, Inc. Miscellaneous Commercial ServicesCommercial Services Cellanome, Inc. is a company based in Palo Alto, CA. Cellanome, Inc. has brought together an experienced team with expertise in sequencing, microfluidics, integrated sensors, information technology, molecular biology, and biochemistry. The company is fortunate to partner with leading life science investors who share their passion and long-term vision. The company was founded by Mostafa Ronaghi and the CEO is Omead Ostadan. | Directeur Général | - |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 13/04/2023 |
Anciens postes connus de Omead Ostadan
Sociétés | Poste | Fin |
---|---|---|
SEER, INC. | President | 30/09/2022 |
ILLUMINA, INC. | Directeur des opérations | 01/06/2020 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | Sales & Marketing | 26/01/2007 |
Formation de Omead Ostadan
University of California, Davis | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ILLUMINA, INC. | Health Technology |
SEER, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | Health Technology |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Cellanome, Inc.
Cellanome, Inc. Miscellaneous Commercial ServicesCommercial Services Cellanome, Inc. is a company based in Palo Alto, CA. Cellanome, Inc. has brought together an experienced team with expertise in sequencing, microfluidics, integrated sensors, information technology, molecular biology, and biochemistry. The company is fortunate to partner with leading life science investors who share their passion and long-term vision. The company was founded by Mostafa Ronaghi and the CEO is Omead Ostadan. | Commercial Services |